Abstract
The active metabolite of vitamin D 1,25-dihydroxycholecalciferol is a hormone-like agent that regulates cell differentiation and proliferation. Various vitamin D derivatives have been shown to induce differentiation in neoplastic cells. The prerequisite for any hormone action is the presence of its receptor. We studied the expression of vitamin D receptor in human lung cancer cell lines and in primary lung cancer tissue. Employing the polymerase chain reaction, 10 out of 11 cell lines stemming from small-cell lung cancer and 15 out of 15 cell lines stemming from non-small-cell lung cancer demonstrated vitamin D receptor expression. An immunohistochemical analysis, using a specific monoclonal antibody, demonstrated vitamin D receptor protein expression in 31 out of 117 (26%) primary small-cell lung cancer cases tested. Positive cells exhibited a nuclear reaction pattern. Twenty-one out of 37 primary non-small-cell lung cancer cases, particularly adenocarcinomas (9/14) and squamous-cell carcinomas (10/15), exhibited vitamin D receptor. Results indicate that a subset of lung cancer cases may be susceptible to the differentiating effects of vitamin D analogues.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beattie CW, Hansen NW, Thomas PA (1985) Steroid receptors in human lung cancer. Cancer Res 45: 4206–4214
Beppler G, Jaques G, Neumann K, Aumüller G, Gropp C, Havemann K (1987) Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell lines. J Cancer Res Clin Oncol 13: 31–40
Berg J, Nilsson K, Ekman R, Giovanella B (1985) Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. Acta Pathol Microbiol Immunol Scand Sect A 93: 133–147
Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD (1985) Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45: 2913–2923
Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG (1991) High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene 6: 1859–1868
Giard JD, Aaronson SA, Todardo GJ, Arnstein P, Kersey JH, Dosik H, Parks WP (1973) In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417–1423
Hofmann J, Kaiser U, Maasberg M, Havemann K (1995) Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines. Eur J Cancer 31A: 2053–2058
Kaiser U, Hofmann J, Wegmann B, Klotz U, Wedel S, Virmani AK, Wollmer E, Gazdar AF, Havemann K (1996) Detection of steroid hormone receptors in human lung cancer cell lines. Int J Cancer (in press)
Maasberg M, Rotsch M, Jaques G, Enderle-Schmidt U, Weehle R, Havemann K (1989) Androgen receptors, androgen-dependent proliferation, and 5α-reductase activity of small-cell lung cancer cell lines. Int J Cancer 43: 685–691
Pettengill OS, Sorenson GD, Wurster-Hill DH, Curphey TJ, Noll WW, Cate CC, Maurer LH (1980) Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer 45: 906–918
Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldmann D (1994) Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54: 805–810
Reichel H, Koeffler P, Normann AW (1989) The role of vitamin D endocrine system in health and disease. N Engl J Med 320: 980–991
Sandgren M, Danforth L, Plasse TF, DeLuca HF (1991) 1,25-Dihydroxyvitamin D3 receptors in human carcinomas: a pilot study. Cancer Res 51: 2021–2024
Shabahang M, Buras RR, Davoodi F, Schumaker LM, Russel JN, Uskokovic MR, Brenner RV, Evans SRT (1994) Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Cancer Res 54: 4057–4064
Smith JM, Anzano MA, Cubert J, Letterio J, Sporn MB (1993) Inhibition of mammary carcinogenesis in the rat by a new vitamin D analog. Proc Am Assoc Cancer Res 34: 128
Sporn MB, Anzano MA, Smith JM, Danielpour D, Cubert J, Letterio JJ, Roberts AB (1993) Prevention of carcinogenesis with Vitamin D analogs. Proc Am Assoc Cancer Res 34: 622
Zhou JY, Normann AW, Akashi M, Chen DL, Uskokvic MR, Aurrecoechea JM, Dauben WG, Okamura WH, Koeffler HP (1991) Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood 78: 75–82
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaiser, U., Schilli, M., Wegmann, B. et al. Expression of vitamin D receptor in lung cancer. J Cancer Res Clin Oncol 122, 356–359 (1996). https://doi.org/10.1007/BF01220803
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01220803